Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 91


Inhibition of HGF/MET as therapy for malignancy.

Naran S, Zhang X, Hughes SJ.

Expert Opin Ther Targets. 2009 May;13(5):569-81. doi: 10.1517/14728220902853917 . Review.


Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.

Yip WK, Abdullah MA, Yusoff SM, Seow HF.

Clin Exp Immunol. 2009 Mar;155(3):412-22. doi: 10.1111/j.1365-2249.2008.03793.x.


Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.

Klibi J, Niki T, Riedel A, Pioche-Durieu C, Souquere S, Rubinstein E, Le Moulec S, Guigay J, Hirashima M, Guemira F, Adhikary D, Mautner J, Busson P.

Blood. 2009 Feb 26;113(9):1957-66. doi: 10.1182/blood-2008-02-142596. Epub 2008 Nov 12. Erratum in: Blood. 2009 Oct 29;114(18):3974. Moulec, Sylvestre L E [corrected to Le Moulec, Sylvestre].


Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes.

Chang KP, Hao SP, Chang JH, Wu CC, Tsang NM, Lee YS, Hsu CL, Ueng SH, Liu SC, Liu YL, Wei PC, Liang Y, Chang YS, Yu JS.

Clin Cancer Res. 2008 Nov 1;14(21):6979-87. doi: 10.1158/1078-0432.CCR-08-0090.


Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells.

Baumforth KR, Birgersdotter A, Reynolds GM, Wei W, Kapatai G, Flavell JR, Kalk E, Piper K, Lee S, Machado L, Hadley K, Sundblad A, Sjoberg J, Bjorkholm M, Porwit AA, Yap LF, Teo S, Grundy RG, Young LS, Ernberg I, Woodman CB, Murray PG.

Am J Pathol. 2008 Jul;173(1):195-204. doi: 10.2353/ajpath.2008.070845. Epub 2008 May 23.


Itinerant exosomes: emerging roles in cell and tissue polarity.

Lakkaraju A, Rodriguez-Boulan E.

Trends Cell Biol. 2008 May;18(5):199-209. doi: 10.1016/j.tcb.2008.03.002. Epub 2008 Apr 7. Review.


Nitric oxide and immune response.

Tripathi P.

Indian J Biochem Biophys. 2007 Oct;44(5):310-9. Review.


Exosome function: from tumor immunology to pathogen biology.

Schorey JS, Bhatnagar S.

Traffic. 2008 Jun;9(6):871-81. doi: 10.1111/j.1600-0854.2008.00734.x. Epub 2008 Mar 6. Review.


Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.

Ma N, Kawanishi M, Hiraku Y, Murata M, Huang GW, Huang Y, Luo DZ, Mo WG, Fukui Y, Kawanishi S.

Int J Cancer. 2008 Jun 1;122(11):2517-25. doi: 10.1002/ijc.23415.


Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy.

Li J, Zeng XH, Mo HY, Rolén U, Gao YF, Zhang XS, Chen QY, Zhang L, Zeng MS, Li MZ, Huang WL, Wang XN, Zeng YX, Masucci MG.

PLoS One. 2007 Nov 7;2(11):e1122.


Tumour-released exosomes and their implications in cancer immunity.

Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, Rivoltini L.

Cell Death Differ. 2008 Jan;15(1):80-8. Epub 2007 Oct 12. Review.


A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma.

Houali K, Wang X, Shimizu Y, Djennaoui D, Nicholls J, Fiorini S, Bouguermouh A, Ooka T.

Clin Cancer Res. 2007 Sep 1;13(17):4993-5000.


Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO.

Nat Cell Biol. 2007 Jun;9(6):654-9. Epub 2007 May 7.


Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line.

Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH.

Cancer Res. 2007 Apr 15;67(8):3716-24.


Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.

Sebelin-Wulf K, Nguyen TD, Oertel S, Papp-Vary M, Trappe RU, Schulzki A, Pezzutto A, Riess H, Subklewe M.

Transpl Immunol. 2007 Apr;17(3):203-10. Epub 2006 Nov 29.


High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance.

Caggiari L, Guidoboni M, Vaccher E, Barzan L, Franchin G, Gloghini A, Martorelli D, Zancai P, Bortolin MT, Mazzucato M, Serraino D, Carbone A, De Paoli P, Dolcetti R.

Infect Agent Cancer. 2007 Mar 1;2:5.


Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.

Klein E, Kis LL, Klein G.

Oncogene. 2007 Feb 26;26(9):1297-305. Review.


Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients.

Lau KM, Cheng SH, Lo KW, Lee SA, Woo JK, van Hasselt CA, Lee SP, Rickinson AB, Ng MH.

Br J Cancer. 2007 Feb 26;96(4):617-22. Epub 2007 Jan 30.


Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.

Keryer-Bibens C, Pioche-Durieu C, Villemant C, Souquère S, Nishi N, Hirashima M, Middeldorp J, Busson P.

BMC Cancer. 2006 Dec 8;6:283.


Cancer despite immunosurveillance: immunoselection and immunosubversion.

Zitvogel L, Tesniere A, Kroemer G.

Nat Rev Immunol. 2006 Oct;6(10):715-27. Epub 2006 Sep 15. Review.


Supplemental Content

Support Center